The abstract is read at the publisher; the summary is JClub's.
PACAP38 produces greater early vasodilation in dural than pial vessels in freely moving mice, and anti-PACAP pretreatment attenuates this PACAP38-induced response.
- Why it matters: Net cephalic vasodilation is used clinically to gauge PACAP pathway inhibition, but the specific vascular compartments driving the response remain unclear.
- What they did: In mice with chronic cranial windows and head-mounted microscopy, researchers tracked meningeal vascular responses to nitroglycerin, levcromakalim, and PACAP38, then tested anti-PACAP pretreatment effects.
- The result: Vessel-level heterogeneity shows that net vasodilation can mask compartment-specific patterns, enabling a spatially defined, pharmacologically modifiable early dural vasodilation readout for evaluating PACAP-targeted migraine therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.